Home Featured Page 172

Featured

Latest

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...

Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life

Stephen Bardin to Join atai Life Sciences as CFO Designate

Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental...

Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine...

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians...

Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet...

Numinus Applies for International Patent Filing of Psychedelics Production Process

Small Pharma Reports Highlights for the Fiscal Year Ended February 28,...

Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and...

Mindmed Announces Voting Results for Annual General and Special Meeting

EDITOR PICKS

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin,...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...

Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life

Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life

Stephen Bardin to Join atai Life Sciences as CFO Designate

Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental...

Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine...

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians...

Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet...

Numinus Applies for International Patent Filing of Psychedelics Production Process

Small Pharma Reports Highlights for the Fiscal Year Ended February 28,...

Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and...

Mindmed Announces Voting Results for Annual General and Special Meeting

EDITOR PICKS

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin,...

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin,...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY